Court of Justice rules in favour of Neurim and SPCs
19 July 2012
|
Simon Crompton, London
The Court of Justice of the EU ruled this morning that supplementary protection certificates (SPCs) can be obtained for second medical use patents
The questions to the Court were referred by Lord Justice Jacob from the Court of Appeal in London, in a case between Neurim Pharmaceuticals and the UK IP Office.
The IPO had refused an...
Only subscribers have complete access to Managing IP,
log in or
subscribe now.
Alternatively take a
free trial, giving you seven days access to Managing IP and regular newsletters for the international IP community, and US and Canadian practitioners specifically.
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial